NCT06616857

Brief Summary

The goal of this clinical trial is to help adolescents and young adults between the ages of 13-25 with Cystic Fibrosis (CF), medically stable, able to speak and read English, and are not experiencing a CF - related exacerbation, who are already active to remain, or gradually encourage them to increase their levels of physical activity Participants will be asked to utilize a smartphone program, called NUDGE that we have developed. NUDGE is a chatbot with evidence-based features known to help teens make progress toward health goal:

  • Set and review goals
  • Self-monitor progress
  • Provide feedback on goal attainment
  • Revise future goals

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
2mo left

Started Feb 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress89%
Feb 2025Jul 2026

First Submitted

Initial submission to the registry

September 20, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

September 27, 2024

Completed
5 months until next milestone

Study Start

First participant enrolled

February 18, 2025

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2026

Last Updated

March 13, 2026

Status Verified

February 1, 2026

Enrollment Period

1.4 years

First QC Date

September 20, 2024

Last Update Submit

March 11, 2026

Conditions

Keywords

physical activity

Outcome Measures

Primary Outcomes (4)

  • Recruitment

    Recruitment: Our recruitment goal is 30 AYAs with CF.

    Baseline

  • Retention

    Retention: Our criterion for success is no more than 20% attrition.

    3-month

  • Engagement

    Engagement: We will be considered engagement a success if AYAs in NUDGE respond to an average of 4/7 (57%) messages each week during the first 3 months that a participant uses NUDGE.

    3-month

  • Acceptability

    Acceptability: We will consider NUDGE acceptable if users report a satisfaction rating of ≥3 (mostly satisfied) on our modified Client Satisfaction Questionnaire and rate it as usable as ≥70% of other computerized systems on the System Usability Scale. We will also be attentive to themes in relation to the barriers and facilitators of using NUDGE and its success in promoting PA in interviews.

    3-month

Secondary Outcomes (3)

  • Actigraphy

    Baseline, 3-month, and 6-month

  • Lung Functioning

    Baseline, 3-month, and 6-month

  • CF Quality of Life

    Baseline, 3-month, and 6-month

Study Arms (2)

NUDGE

EXPERIMENTAL
Behavioral: NUDGE

Education

ACTIVE COMPARATOR
Other: Education

Interventions

NUDGEBEHAVIORAL

Individuals in this condition will receive intervention content to promote physical activity.

NUDGE

Individuals will receive educational materials about how to increase physical activity

Education

Eligibility Criteria

Age13 Years - 25 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • years old
  • Has a verified CF diagnosis or CF-related disorder
  • Medically stable (i.e., FEV1\>30%, not experiencing a CF-related exacerbation)
  • Speaks and reads English

You may not qualify if:

  • Have a comorbidity limiting PA participation (e.g., neurological condition)
  • Have a significant cognitive impairment that interferes with study completion
  • Have any oxygen, CPAP or BiPAP requirement

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Nemours Childrens Health

Jacksonville, Florida, 32207, United States

RECRUITING

MeSH Terms

Conditions

Cystic FibrosisMotor Activity

Interventions

Educational Status

Condition Hierarchy (Ancestors)

Pancreatic DiseasesDigestive System DiseasesLung DiseasesRespiratory Tract DiseasesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesInfant, Newborn, DiseasesBehavior

Intervention Hierarchy (Ancestors)

Socioeconomic FactorsPopulation Characteristics

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Research Scientist

Study Record Dates

First Submitted

September 20, 2024

First Posted

September 27, 2024

Study Start

February 18, 2025

Primary Completion (Estimated)

July 1, 2026

Study Completion (Estimated)

July 1, 2026

Last Updated

March 13, 2026

Record last verified: 2026-02

Locations